Nizamuddin Sheikh, Dubey Shivendra, Singh Sakshi, Sharma Saurav, Machha Pratheusa, Thangaraj Kumarasamy
CSIR-Centre for Cellular and Molecular Biology, Hyderabad 500007, India.
German Cancer Consortium (DKTK) c/o Zentrale Klinische Forschung (ZKF), University Medical Center, Freiburg, Germany.
Pharmgenomics Pers Med. 2021 Jan 27;14:135-147. doi: 10.2147/PGPM.S272015. eCollection 2021.
Allelic frequency distribution of drug metabolizing enzyme genes among populations is important to identify risk groups for adverse drug reaction and to select representative populations for clinical trials. Although India emerged as an important hub for clinical trials, information about the pharmacogenetic diversity for this region is still lacking. Here, we investigated genetic diversity of cytochrome-P450-2C9 () gene which metabolizes wide range of drugs and is highly expressed in the human liver.
In total, 1278 individuals from 36 diverse Indian populations, 210 individuals from in-house data-repository and 489 other South Asian samples from the 1000 Genomes Project were selected. Variants observed in gene were subjected to various statistical analyses.
High frequency of (13%) and (1%) was observed among South Asians, compared to 21 populations living outside the Indian subcontinent. The allelic/genotypic frequency does not correlate with geographical location or linguistic affiliation, except populations speaking Tibeto-Burmans language, who have lower frequency of and . Since, South Asians practice strict endogamy, presence of unique mutation and high frequency of homozygous genotypes not surprising. has been associated with therapeutic response.The effect of is more pronounced compared to heterozygous and wild type homozygous genotypes as evident in many studies. As South Asians have high frequency, it would be interesting to explore potential of as a marker for personalized therapy. Our study revealed several rare functional variants, which form eight novel and rare haplotypes of (*63-*70). Of which, and haplotypes are South Asian-specific.
Overall, we find high genetic heterogeneity within South Asians and identified South Asian-specific putative functional haplotypes. High frequency of and was observed in South Asian populations. Taken together, current study greatly enriches the knowledge of naturally occurring variants and its diversity in South Asia, which are relevant to further -related functional research and for personalized medicine.
药物代谢酶基因在人群中的等位基因频率分布对于识别药物不良反应的风险群体以及选择临床试验的代表性人群至关重要。尽管印度已成为临床试验的重要中心,但该地区药物遗传学多样性的信息仍然匮乏。在此,我们研究了细胞色素P450 - 2C9(CYP2C9)基因的遗传多样性,该基因可代谢多种药物且在人类肝脏中高度表达。
总共选取了来自36个不同印度人群的1278名个体、来自内部数据存储库的210名个体以及来自千人基因组计划的489个其他南亚样本。对在CYP2C9基因中观察到的变异进行了各种统计分析。
与居住在印度次大陆以外的21个群体相比,在南亚人群中观察到CYP2C93(~13%)和CYP2C92(~1%)的高频率。等位基因/基因型频率与地理位置或语言归属无关,但说藏缅语的人群除外,他们的CYP2C93和CYP2C92频率较低。由于南亚人实行严格的族内通婚,独特突变的存在和纯合基因型的高频率并不令人惊讶。CYP2C93已与治疗反应相关联。正如许多CYP2C9研究中所表明的,CYP2C93的作用与杂合子和野生型纯合基因型相比更为明显。由于南亚人群中CYP2C9*3频率较高,探索其作为个性化治疗标志物的潜力将很有趣。我们的研究揭示了几个罕见的功能变异,它们形成了CYP2C9的八种新的罕见单倍型(*63 - *70)。其中,64和65单倍型是南亚特有的。
总体而言,我们发现南亚人群内部存在高度的遗传异质性,并确定了南亚特有的推定功能性CYP2C9单倍型。在南亚人群中观察到CYP2C93和CYP2C92的高频率。综上所述,当前研究极大地丰富了南亚地区自然发生的CYP2C9变异及其多样性的知识,这与进一步的CYP2C9相关功能研究和个性化医学相关。